KPRX
Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)
$47
About Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)
Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
Details
Daily high
$2.52
Daily low
$2.42
Price at open
$2.50
52 Week High
$3.29
52 Week Low
$1.76
Market cap
11.2M
Dividend yield
0.00%
Volume
20,475
Avg. volume
31,819
P/E ratio
-.89
Kiora Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$2.52
Daily low
$2.42
Price at open
$2.50
52 Week High
$3.29
52 Week Low
$1.76
Market cap
11.2M
Dividend yield
0.00%
Volume
20,475
Avg. volume
31,819
P/E ratio
-.89